Walleye Capital LLC Corcept Therapeutics Inc Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $11,105 - $17,240	500 New	500 $16,000
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $222,720 - $283,852	11,600 New	11,600 $251,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $138,320 - $163,072	5,600 New	5,600 $144,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $16,176 - $22,464	-1,600 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $19,296 - $27,136	1,600 New	1,600 $19,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $275,796 - $359,832	-28,200 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $282,846 - $443,022	28,200 New	28,200 $331,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.